Mass General Brigham Launches Trials of Blood Test to Guide Post-Surgery Cancer Care
Two studies will evaluate circulating tumor DNA as a guide for post-surgical cancer treatment decisions.
Two studies will evaluate circulating tumor DNA as a guide for post-surgical cancer treatment decisions.
NeoGenomics and Ultima Genomics have partnered to use the UG 100 sequencing platform to advance precision oncology diagnostics.
New England Biolabs showcased advanced sample preparation technologies at AGBT, focusing on improved sequencing data quality and efficiency.
Two studies demonstrate the potential of a genomic screening platform to improve early detection of genetic diseases in newborns.
Read MoreNIH researchers found undetected cancers in nearly half of pregnant people with abnormal prenatal cfDNA test results.
Read MoreScientists have developed a deep learning model that utilizes DNA breathing to predict transcription factor binding.
Read MoreAzenta, Inc. has launched a long-read whole genome sequencing test for clinical use, offering accuracy in detecting genetic variants.
Read MoreResearchers have developed a novel testing strategy for mesothelioma cancer, focusing on detecting chromosomal rearrangements in cancer DNA.
Read MoreMultitarget stool DNA testing is a highly sensitive, non-invasive method for colorectal cancer screening, offering a colonoscopy alternative.
Read MoreLucid Diagnostics secured a patent allowance for its proprietary method of using CCNA1 gene methylation to detect esophageal cancer.
Read MoreResearchers developed AI-powered PCR tech that improves DNA profiling, offering more reliable results for medical applications and more.
Read MoreResearchers developed a DNA barcode-based technology that maps complex protein interactions, enabling more precise cancer diagnostics.
Read MoreStool-based tests are promising alternatives to colonoscopy for colorectal cancer screening, addressing global accessibility challenges.
Read MoreA new prostate cancer screening method could help better predict which patients need to undergo a biopsy, reducing unnecessary procedures.
Read MoreLucid Diagnostics announced the peer-reviewed publication of an analytical validation study for its EsoGuard Esophageal DNA test.
Read MoreA study identified genetic causes for many ultra-rare diseases, discovering new diseases and enhancing diagnostic accuracy.
Read MoreResearchers developed a urine test using ELISA to detect HPV16 E7 oncoproteins, a noninvasive method for cervical cancer screening.
Read MoreResearchers developed a new lab test to detect intact HIV infections with African strains, crucial for advancing global HIV cure efforts.
Read More